Reed Smith

Reed Smith maintains a strong position in the healthcare and life sciences market, with the team’s wide-ranging expertise encompassing product liability litigation, competition compliance risk assessments and tender disputes. The group is co-headed by Natasha Tardif, Marc Lévy and Daniel Kadar. Tardif has strong credentials in advising on competition law issues within the pharmaceutical sector, as well as advising on merger notifications. Lévy specialises in antitrust litigation and competition compliance, while Kadar stands out for his work in complex litigation and cross-border disputes.